Edition:
United States

Kura Oncology Inc (KURA.OQ)

KURA.OQ on NASDAQ Stock Exchange Global Select Market

23.00USD
10:44am EST
Change (% chg)

$0.80 (+3.60%)
Prev Close
$22.20
Open
$22.20
Day's High
$23.00
Day's Low
$22.20
Volume
14,074
Avg. Vol
79,455
52-wk High
$24.00
52-wk Low
$5.90

Latest Key Developments (Source: Significant Developments)

Kura Oncology files for mixed shelf offering of up to $200 mln - SEC filing‍​
Thursday, 9 Nov 2017 05:28pm EST 

Nov 9 (Reuters) - Kura Oncology Inc :Kura Oncology Inc - files for mixed shelf offering of up to $200 million - SEC filing‍​.  Full Article

Kura Oncology reports third quarter 2017 financial results
Tuesday, 7 Nov 2017 04:05pm EST 

Nov 7 (Reuters) - Kura Oncology Inc ::Kura Oncology reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $0.38.Q3 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.  Full Article

KURA ONCOLOGY ‍CONFIRMS PARTIAL RESPONSES OBSERVED IN PATIENTS WITH HRAS MUTANT HNSCC IN TRIAL
Friday, 27 Oct 2017 10:50am EDT 

Oct 27 (Reuters) - Kura Oncology Inc :KURA ONCOLOGY LEAD CANDIDATE TIPIFARNIB SHOWS DURABLE ANTI-TUMOR ACTIVITY IN HRAS MUTANT HEAD AND NECK CANCER IN AACR-NCI-EORTC UPDATE.‍CONFIRMED PARTIAL RESPONSES OBSERVED IN FOUR OUT OF SIX PATIENTS WITH HRAS MUTANT HNSCC IN TRIAL​.BASED ON POSITIVE RESULTS FROM PHASE 2 TRIAL, CO PLANS TO INITIATE A REGISTRATION-ENABLING STUDY IN HRAS MUTANT HNSCC IN 2018​.  Full Article

‍Great Point Partners LLC reports 5.92 percent passive stake ​in Kura Oncology Inc
Monday, 21 Aug 2017 04:18pm EDT 

Aug 21 (Reuters) - ‍Great Point Partners LLC::‍Great Point Partners LLC reports 5.92 percent passive stake ​in Kura Oncology Inc <<>> as on August 11, 2017 - sec filing.  Full Article

Kura Oncology prices public offering of 7.70 mln common shares at $6.50 per share
Thursday, 10 Aug 2017 10:11pm EDT 

Aug 10 (Reuters) - Kura Oncology Inc :Kura oncology announces pricing of public offering of common stock.Says public offering of 7.70 million common shares priced at $6.50 per share.  Full Article

Kura Oncology announces commencement of public offering of common stock
Wednesday, 9 Aug 2017 04:17pm EDT 

Aug 10 (Reuters) - Kura Oncology Inc -:Kura Oncology announces commencement of public offering of common stock.Kura Oncology Inc - ‍commenced an underwritten public offering to issue and sell up to 5.3 million shares of its common stock​.  Full Article

Kura Oncology Q2 loss per share $0.40
Monday, 7 Aug 2017 04:05pm EDT 

Aug 7 (Reuters) - Kura Oncology Inc :Kura Oncology reports second quarter 2017 financial results and provides update on Tipifarnib phase 2 study.Q2 loss per share $0.40.Q2 earnings per share view $-0.43 -- Thomson Reuters I/B/E/S.  Full Article

Kura announces issuance of U.S. patent for tipifarnib in head and neck cancer
Tuesday, 18 Jul 2017 07:30am EDT 

July 18 (Reuters) - Kura Oncology Inc ::Kura Oncology announces issuance of U.S. Patent for lead product candidate tipifarnib in head and neck cancer.Kura Oncology says patent includes multiple claims directed to use of tipifarnib in patients with HRAS mutant squamous cell carcinoma of head and neck.Kura Oncology says patent has an expiration date of august 2036, excluding any possible patent term extension.  Full Article

Kura Oncology ‍enters into collaboration agreement with Foundation Medicine ​
Thursday, 13 Jul 2017 07:30am EDT 

July 13 (Reuters) - Foundation Medicine Inc -:Kura Oncology Inc - ‍entered into a collaboration agreement with Foundation Medicine, Inc.​.Kura Oncology Inc - collaboration to support patient enrollment for co's clinical program for tipifarnib.  Full Article

Kura Oncology Q1 loss per share $0.39
Monday, 15 May 2017 04:05pm EDT 

May 15 (Reuters) - Kura Oncology Inc :Kura Oncology reports first quarter 2017 operational and financial results.Q1 loss per share $0.39.Q1 earnings per share view $-0.44 -- Thomson Reuters I/B/E/S.Kura Oncology Inc - expects that current cash, cash equivalents and short-term investments will be sufficient to fund current operations into second half of 2018..  Full Article

BRIEF-Kura Oncology files for mixed shelf offering of up to $200 mln - SEC filing‍​

* Kura Oncology Inc - files for mixed shelf offering of up to $200 million - SEC filing‍​ Source text:(http://bit.ly/2yNnKBA) Further company coverage: